Accession Therapeutics Limited
Tony Hinton currently serves as the IT Manager at Accession Therapeutics Limited, a position held since September 2021. Prior to this role, Tony was the IT Manager at Prior's Court Foundation from October 2017 to April 2021, where responsibilities included managing the daily operations of the IT department and overseeing the internal IT team through mentoring and performance reviews. Tony also has experience as an IT Security Analyst and Project Controller, as well as Service Desk Manager at Adaptimmune Ltd from 2012 to April 2017.
This person is not in any teams
Accession Therapeutics Limited
Accession Therapeutics’ elegant Trocept platform has potential to treat some of the most intractable and widespread forms of cancer. Based in Oxford, UK, it is developing a pipeline of products to the early clinical trial stage. Led by Bent Jakobsen, PhD FMedSci, a pioneer of T cell receptor therapy for cancer, the team is highly experienced intaking immuno-oncology products to the clinic. Accession Therapeutics’ Trocept technology is based on over a decade’s work and has generated exceptional preclinical data.Accession Therapeutics’ proprietary technology incorporates cancer-tropic viruses, the first time that viruses have been genetically modified to exclusively target cancer cells.As non-cancerous cells are not targeted by Trocept, systemic toxicity is eliminated meaning the drugs can be delivered intravenously and traffic to the tumour.Trocept’s highly potent and local activity gives it potential in some of the hardest to treat and most widespread forms of cancer. This includes breast, cervical, colorectal, gastric, head and neck, lung, oral, ovarian and pancreatic cancer.